Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK

V. Becerra; A. Gracia; K. Desai; S. Abogunrin; S. Brand; R. Chapman; F. Garcia Alonso; V. Fuster; G. Sanz

doi:10.1136/bmjopen-2014-007111

Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK

BMJ Open ◽

10.1136/bmjopen-2014-007111 ◽

2015 ◽

Vol 5 (5) ◽

pp. e007111-e007111 ◽

Cited By ~ 47

Author(s):

V. Becerra ◽

A. Gracia ◽

K. Desai ◽

S. Abogunrin ◽

S. Brand ◽

...

Keyword(s):

Public Health ◽

Cardiovascular Disease ◽

Cost Effectiveness ◽

Disease Prevention ◽

Health Benefit ◽

Cardiovascular Disease Prevention ◽

Public Health Benefit ◽

The Uk

Download Full-text

A protocol paper: community engagement interventions for cardiovascular disease prevention in socially disadvantaged populations in the UK: an implementation research study

Global Health Research and Policy ◽

10.1186/s41256-020-0131-1 ◽

2020 ◽

Vol 5 (1) ◽

Author(s):

Papreen Nahar ◽

Harm van Marwijk ◽

Linda Gibson ◽

Geofrey Musinguzi ◽

Sibyl Anthierens ◽

...

Keyword(s):

Cardiovascular Disease ◽

Disease Prevention ◽

Community Engagement ◽

Implementation Research ◽

Research Study ◽

Cardiovascular Disease Prevention ◽

Disadvantaged Populations ◽

Socially Disadvantaged ◽

Engagement Interventions ◽

The Uk

Download Full-text

Cost-Effectiveness of Statin Plus Eicosapentaenoic Acid Combination Therapy for Cardiovascular Disease Prevention in Japanese Patients With Hypercholesterolemia　― An Analysis Based on the Japan Eicosapentaenoic Acid Lipid Intervention Study (JELIS) ―

Circulation Journal ◽

10.1253/circj.cj-17-0995 ◽

2018 ◽

Vol 82 (4) ◽

pp. 1076-1082 ◽

Cited By ~ 10

Author(s):

Satoshi Kodera ◽

Hiroyuki Morita ◽

Arihiro Kiyosue ◽

Jiro Ando ◽

Issei Komuro

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Combination Therapy ◽

Disease Prevention ◽

Eicosapentaenoic Acid ◽

Intervention Study ◽

Japanese Patients ◽

Cardiovascular Disease Prevention

Download Full-text

Cost effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjo, Sweden.

Journal of Epidemiology & Community Health ◽

10.1136/jech.50.2.190 ◽

1996 ◽

Vol 50 (2) ◽

pp. 190-195 ◽

Cited By ~ 26

Author(s):

L Lindholm ◽

M Rosen ◽

L Weinehall ◽

K Asplund

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Disease Prevention ◽

Cardiovascular Disease Prevention ◽

Prevention Programme ◽

Community Based

Download Full-text

Combination Polypharmacy for Cardiovascular Disease Prevention in Men: A Decision Analysis and Cost-Effectiveness Model

Preventive Cardiology ◽

10.1111/j.1520-037x.2007.06423.x ◽

2008 ◽

Vol 11 (1) ◽

pp. 36-41 ◽

Cited By ~ 7

Author(s):

Jonathan Newman ◽

William A. Grobman ◽

Philip Greenland

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Disease Prevention ◽

Decision Analysis ◽

Cardiovascular Disease Prevention ◽

Effectiveness Model

Download Full-text

Represcription of Low-Dose Acetylsalicylic Acid After Discontinuation in Patients Receiving Treatment for Secondary Cardiovascular Disease Prevention in the UK

American Journal of Cardiovascular Drugs ◽

10.1007/s40256-014-0079-y ◽

2014 ◽

Vol 14 (4) ◽

pp. 319-326 ◽

Cited By ~ 4

Author(s):

Elisa Martín-Merino ◽

Saga Johansson ◽

Péter Nagy ◽

Luis A. García Rodríguez

Keyword(s):

Cardiovascular Disease ◽

Disease Prevention ◽

Acetylsalicylic Acid ◽

Low Dose ◽

Cardiovascular Disease Prevention ◽

The Uk

Download Full-text

Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam

PLoS ONE ◽

10.1371/journal.pone.0155699 ◽

2016 ◽

Vol 11 (5) ◽

pp. e0155699 ◽

Cited By ~ 8

Author(s):

Thi-Phuong-Lan Nguyen ◽

E. Pamela Wright ◽

Thanh-Trung Nguyen ◽

C. C. M. Schuiling-Veninga ◽

M. J. Bijlsma ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Disease Prevention ◽

Cost Effectiveness Analysis ◽

Cardiovascular Disease Prevention ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness of cardiovascular disease prevention and management in the developing world

Nature Reviews Cardiology ◽

10.1038/nrcardio.2012.42 ◽

2012 ◽

Vol 9 (5) ◽

pp. 258-258 ◽

Cited By ~ 1

Author(s):

Alexandra King

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Disease Prevention ◽

Developing World ◽

Cardiovascular Disease Prevention

Download Full-text

A computer simulation model for cost-effectiveness analysis of cardiovascular disease prevention

Medical Informatics ◽

10.3109/14639239109067657 ◽

1991 ◽

Vol 16 (4) ◽

pp. 355-362 ◽

Cited By ~ 19

Author(s):

M. Johannesson ◽

J. Hedbrant ◽

B. Jönsson

Keyword(s):

Cardiovascular Disease ◽

Computer Simulation ◽

Cost Effectiveness ◽

Disease Prevention ◽

Simulation Model ◽

Cost Effectiveness Analysis ◽

Cardiovascular Disease Prevention ◽

Computer Simulation Model ◽

Effectiveness Analysis

Download Full-text

The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model

BMJ Open ◽

10.1136/bmjopen-2014-005376 ◽

2014 ◽

Vol 4 (9) ◽

pp. e005376-e005376 ◽

Cited By ~ 26

Author(s):

P. Laramee ◽

T.-H. Brodtkorb ◽

N. Rahhali ◽

C. Knight ◽

C. Barbosa ◽

...

Keyword(s):

Public Health ◽

Cost Effectiveness ◽

Alcohol Consumption ◽

Psychosocial Support ◽

Health Benefit ◽

Public Health Benefit ◽

Risk Levels ◽

The Cost ◽

Very High ◽

Alcohol Dependent

Download Full-text

Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study

BMC Public Health ◽

10.1186/1471-2458-12-398 ◽

2012 ◽

Vol 12 (1) ◽

Cited By ~ 33

Author(s):

Linda J Cobiac ◽

Anne Magnus ◽

Jan J Barendregt ◽

Rob Carter ◽

Theo Vos

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Disease Prevention ◽

Cardiovascular Disease Prevention ◽

The Cost ◽

Modelling Study

Download Full-text

Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK

A protocol paper: community engagement interventions for cardiovascular disease prevention in socially disadvantaged populations in the UK: an implementation research study

Cost-Effectiveness of Statin Plus Eicosapentaenoic Acid Combination Therapy for Cardiovascular Disease Prevention in Japanese Patients With Hypercholesterolemia ― An Analysis Based on the Japan Eicosapentaenoic Acid Lipid Intervention Study (JELIS) ―

Cost effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjo, Sweden.

Combination Polypharmacy for Cardiovascular Disease Prevention in Men: A Decision Analysis and Cost-Effectiveness Model

Represcription of Low-Dose Acetylsalicylic Acid After Discontinuation in Patients Receiving Treatment for Secondary Cardiovascular Disease Prevention in the UK

Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam

Cost-effectiveness of cardiovascular disease prevention and management in the developing world

A computer simulation model for cost-effectiveness analysis of cardiovascular disease prevention

The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model

Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study

Cost-Effectiveness of Statin Plus Eicosapentaenoic Acid Combination Therapy for Cardiovascular Disease Prevention in Japanese Patients With Hypercholesterolemia　― An Analysis Based on the Japan Eicosapentaenoic Acid Lipid Intervention Study (JELIS) ―